Related Experiment Video
Updated: Jul 2, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis
Kosei Ito1, Anthony Chee-Beng Lim, Manuel Salto-Tellez
1Institute of Molecular and Cell Biology, Proteos, 61 Biopolis Drive, Singapore 138673.
Abstract:
In intestinal epithelial cells, inactivation of APC, a key regulator of the Wnt pathway, activates beta-catenin to initiate tumorigenesis. However, other alterations may be involved in intestinal tumorigenesis. Here we found that RUNX3, a gastric tumor suppressor, forms a ternary complex with beta-catenin/TCF4 and attenuates Wnt signaling activity. A significant fraction of human sporadic colorectal adenomas and Runx3(+/-) mouse intestinal adenomas showed inactivation of RUNX3 without apparent beta-catenin accumulation, indicating that RUNX3 inactivation independently induces intestinal adenomas. In human colon cancers, RUNX3 is frequently inactivated with concomitant beta-catenin accumulation, suggesting that adenomas induced by inactivation of RUNX3 may progress to malignancy. Taken together, these data demonstrate that RUNX3 functions as a tumor suppressor by attenuating Wnt signaling.
Insights
RUNX3 acts as a tumor suppressor in the gut by inhibiting the Wnt pathway. Its inactivation independently causes intestinal adenomas, which may progress to colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- APC gene mutations activate beta-catenin, initiating Wnt pathway signaling and promoting intestinal tumorigenesis.
- The Wnt pathway plays a crucial role in intestinal epithelial cell regulation and its dysregulation is linked to colorectal cancer.
- Tumor suppressors can act through various mechanisms, including modulation of key signaling pathways like Wnt.
Purpose of the Study:
- To investigate the role of RUNX3 in intestinal tumorigenesis.
- To determine if RUNX3 inactivation can independently induce intestinal adenomas.
- To elucidate the mechanism by which RUNX3 affects Wnt signaling.
Main Methods:
- Analysis of RUNX3 expression and function in human colorectal adenomas and cancers.
- Genomic and molecular analysis of sporadic colorectal adenomas and Runx3(+/-) mouse intestinal adenomas.
- Biochemical assays to assess the interaction of RUNX3 with beta-catenin/TCF4 complex.
Main Results:
- RUNX3 forms a ternary complex with beta-catenin/TCF4, attenuating Wnt signaling.
- RUNX3 inactivation was observed in a significant fraction of human and mouse intestinal adenomas, independent of beta-catenin accumulation.
- RUNX3 inactivation alone can initiate intestinal adenoma formation.
- RUNX3 inactivation frequently co-occurs with beta-catenin accumulation in human colon cancers, suggesting a role in malignant progression.
Conclusions:
- RUNX3 functions as a tumor suppressor in the intestine by attenuating Wnt signaling.
- RUNX3 inactivation is an independent driver of intestinal adenoma formation.
- RUNX3 alterations may contribute to the progression of intestinal adenomas to colon cancer.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal